Schedule 13G ownership disclosure

Edge Therapeutics, Inc.

Security class unavailable · CUSIP: 279870109

Event date: 2020-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,008,362
Percent of class
6.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011034-20-000015
Form type
SC 13G
Filer
PDS Biotechnology Corp
CIK
CIK 1472091
Filed
Feb 21, 2020
Reporting period
Feb 12, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub